About this trial
In the current study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in improving executive function across neuropsychiatric populations known to have deficits in this cognitive domain.
Eligibility criteria
Qualifiers
Male and female outpatients 18-65 years of age
A diagnosis of traumatic brain injury, major depressive disorder, bipolar disorder, schizophrenia, attention deficit hyperactivity disorder, borderline personality disorder and substance use disorders meeting the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.
Disqualifiers
Contraindication to tDCS: history or epilepsy, metallic implants in the head and neck, brain stimulators, vagus nerve stimulators, shunts, pacemakers, pregnancy.
Active substance dependence (except for tobacco and cannabis).
Pregnant or nursing females.
Inability to participate in testing procedures.
Trial design
Treatments tested in this trial
- Transcranial Direct Current Stimulation
Treatment groups
8
Treatment groupsSee each treatment group below.